Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × Dexrazoxane × Clear all

Sponsor

Conditions

Sarcoma 4 Osteosarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia 2 Vomiting 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Recurrence 1 PRETEXT I Hepatoblastoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nausea 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leiomyosarcoma 1 Hypersensitivity 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Ganglioneuroblastoma 1 Fibrosarcoma 1 Extravasations of Anthracycline Anti-cancer Agents 1 Drug-Related Side Effects and Adverse Reactions 1 Dermatofibrosarcoma 1 Degradation of Top2b and Top2a in Human by Dexrazoxane 1

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Dactinomycin 5 temsirolimus 4 cixutumumab 4 Sirolimus 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 X-Rays 3 Radiation 3 Phantoms, Imaging 3 Doxorubicin 3 thymoglobulin 2 fludarabine phosphate 2 eribulin 2 Vinorelbine 2 Temozolomide 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Image-Guided 2 Peripheral Blood Stem Cell Transplantation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Melphalan 2 Ifosfamide 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡